MedTrace Logo

Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis.

NCT02332148 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-08-21

No results posted yet for this study

Summary

3VM1001 is a topical cream that may be useful for the treatment of chronic osteoarthritis of the knee. This proof of concept study is a randomized, placebo-controlled, double-blind study to compare treatment with 3VM1001 cream to an inactive cream placebo. Subjects will self-treat for 30 days.

Conditions

  • Osteoarthritis of Knee

Interventions

DRUG

3VM1001

3VM1001 topical cream for treatment of osteoarthritis of the knee

DRUG

Placebo for 3VM1001

Topical cream placebo for 3VM1001; cream without 3VM1001

Sponsors & Collaborators

  • 3VM Research Group, Inc.

    collaborator OTHER

  • CDA Research Group, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-10-31
Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02332148 on ClinicalTrials.gov